Previous close | 8.60 |
Open | N/A |
Bid | 24.20 |
Ask | 28.50 |
Strike | 97.50 |
Expiry date | 2024-06-21 |
Day's range | 8.60 - 8.60 |
Contract range | N/A |
Volume | |
Open interest | 2 |
BILLERICA, Mass., May 31, 2024--Bruker Corporation (Nasdaq: BRKR) announced today it will present at the following conferences:
Spectronaut® by Biognosys DIA Proteomics Analysis Software Spectronaut® 19 offers significant improvements in identifications, candidate discovery, scalability for large-scale analysis, and support for novel workflowsNovel TrueDiscovery® P2 Plasma Enrichment method offers market-leading performance and superior economics for unbiased, deep plasma proteomicsNew TrueTarget® high-throughput LiP-MS workflow enables large-scale drug target deconvolution screening with improved target identificationDi
Biognosys Newton, Massachusetts proteomics facility Mass spectrometry laboratory The proprietary P2 Plasma Enrichment method leverages a novel single-well, single particle-type enrichment method to achieve market-leading performance for unbiased, deep mass spectrometry-based plasma proteomics P2 now offers excellent quantitation and higher throughput for large-cohort biomarker or drug discovery studies, and clinical, epidemiological or population proteomics research P2 Plasma Enrichment is avail